| Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ... Journal of Clinical Oncology 14 (1), 18-24, 1996 | 1179 | 1996 |
| What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group … W Stock, M La, B Sanford, CD Bloomfield, JW Vardiman, P Gaynon, ... Blood, The Journal of the American Society of Hematology 112 (5), 1646-1654, 2008 | 613 | 2008 |
| Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy JB Nachman, HN Sather, MG Sensel, ME Trigg, JM Cherlow, JN Lukens, ... New England Journal of Medicine 338 (23), 1663-1671, 1998 | 543 | 1998 |
| Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children C Peters, EG Shapiro, J Anderson, PJ Henslee-Downey, MR Klemperer, ... Blood, The Journal of the American Society of Hematology 91 (7), 2601-2608, 1998 | 433 | 1998 |
| Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases FM Uckun, WE Evans, CJ Forsyth, KG Waddick, L Tuel-Ahlgren, ... Science 267 (5199), 886-891, 1995 | 354 | 1995 |
| Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency K Cai, X He, Z Song, Q Yin, Y Zhang, FM Uckun, C Jiang, J Cheng Journal of the American Chemical Society 137 (10), 3458-3461, 2015 | 336 | 2015 |
| Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents EA Sudbeck, XP Liu, RK Narla, S Mahajan, S Ghosh, C Mao, FM Uckun Clinical Cancer Research 5 (6), 1569-1582, 1999 | 332 | 1999 |
| Regulation of human B-cell ontogeny FM Uckun | 332 | 1990 |
| Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins FM Uckun, W Jaszcz, JL Ambrus, AS Fauci, K Gajl-Peczalska, CW Song, ... | 314 | 1988 |
| Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in … GL Schieven, JM Kirihara, DE Myers, JA Ledbetter, FM Uckun | 311 | 1993 |
| Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review PS Gaynon, AA Desai, BC Bostrom, RJ Hutchinson, BJ Lange, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 309 | 1997 |
| Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies JM Zarling, PA Moran, O Haffar, J Sias, DD Richman, CA Spina, DE Myers, ... Nature 347 (6288), 92-95, 1990 | 309 | 1990 |
| Rational design and synthesis of a novel anti-leukemic agent targeting Bruton′ s tyrosine kinase (BTK), LFM-A13 [α-cyano-β-hydroxy-β-methyl-N-(2, 5-dibromophenyl) propenamide] S Mahajan, S Ghosh, EA Sudbeck, Y Zheng, S Downs, M Hupke, ... Journal of Biological Chemistry 274 (14), 9587-9599, 1999 | 303 | 1999 |
| Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. FM Uckun, L Tuel-Ahlgren, CW Song, K Waddick, DE Myers, J Kirihara, ... Proceedings of the National Academy of Sciences 89 (19), 9005-9009, 1992 | 264 | 1992 |
| Biology and treatment of childhood T-lineage acute lymphoblastic leukemia FM Uckun, MG Sensel, L Sun, PG Steinherz, ME Trigg, NA Heerema, ... Blood, The Journal of the American Society of Hematology 91 (3), 735-746, 1998 | 260 | 1998 |
| Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group NA Heerema, JB Nachman, HN Sather, MG Sensel, MK Lee, ... Blood, The Journal of the American Society of Hematology 94 (12), 4036-4045, 1999 | 255 | 1999 |
| Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group GH Reaman, R Sposto, MG Sensel, BJ Lange, JH Feusner, NA Heerema, ... Journal of Clinical Oncology 17 (2), 445-445, 1999 | 253 | 1999 |
| Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia L Sun, N Heerema, L Crotty, X Wu, C Navara, A Vassilev, M Sensel, ... Proceedings of the National Academy of Sciences 96 (2), 680-685, 1999 | 243 | 1999 |
| BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells FM Uckun, KG Waddick, S Mahajan, X Jun, M Takata, J Bolen, T Kurosaki Science 273 (5278), 1096-1100, 1996 | 240 | 1996 |
| Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes) NA Heerema, HN Sather, MG Sensel, T Zhang, RJ Hutchinson, ... Journal of Clinical Oncology 18 (9), 1876-1887, 2000 | 238 | 2000 |
Ilker DibirdikTrakya University在 trakya.edu.tr 的电子邮件经过验证
